Grittgene Therapeutics
GrittGene Therapeutics, located in Glendale, CA, is dedicated to finding a cure for Myotonic Dystrophy by employing cutting-edge technologies such as CRISPR and Artificial Intelligence. Their innovative approach combines tissue-specific delivery, gene-specific editing, and a combination of small-molecule treatments and biologicals to address this multisystemic disorder.
With a mission focused on curing the disease rather than merely alleviating symptoms, GrittGene leverages a wide range of expertise and relationships within the drug discovery sector. Their global laboratories provide diagnostic solutions for clinical trials across multiple continents, emphasizing their commitment to serving people affected by Myotonic Dystrophy.
Generated from the website